actinium has been researched along with Cancer of Pancreas in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bal, C; Chandekar, KR; Satapathy, S | 1 |
Giesel, F; Haberkorn, U; Hatazawa, J; Kaneda-Nakashima, K; Kratochwil, C; Lindner, T; Liu, Y; Nagata, K; Ooe, K; Shimosegawa, E; Shinohara, A; Shirakami, Y; Toyoshima, A; Watabe, T | 1 |
Abdel-Atti, D; Carter, LM; Lewis, JS; Mandleywala, K; Membreno, R; Poty, S; Ragupathi, A; Scholz, WW; Zeglis, BM | 1 |
1 review(s) available for actinium and Cancer of Pancreas
Article | Year |
---|---|
Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: Actinium-225-DOTATATE and Combined Therapies.
Topics: Actinium; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms | 2023 |
2 other study(ies) available for actinium and Cancer of Pancreas
Article | Year |
---|---|
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
Topics: Actinium; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Endopeptidases; Gelatinases; Humans; Isotope Labeling; Male; Membrane Proteins; Mice; Mice, Nude; Molecular Targeted Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Serine Endopeptidases; Tissue Distribution | 2020 |
Leveraging Bioorthogonal Click Chemistry to Improve
Topics: Actinium; Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Click Chemistry; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Immunoconjugates; Mice; Molecular Imaging; Pancreatic Neoplasms; Radiometry; Radiopharmaceuticals; Tissue Distribution; Translational Research, Biomedical; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |